“The reality that most high-schoolers have easier access to cannabis than do our nation’s top scientists is the height of absurdity and an indictment of the current system.”
The post Key Congressional Committee Advances Legislation to Facilitate Clinic…
Category: University of Mississippi
NORML Formally Responds to DEA’s Proposed Changes to Marijuana Cultivation Rules
“We believe that the adoption of these rules may further stonewall efforts to advance our scientific understanding of cannabis by unduly expanding the DEA’s authority and control over decisions that ought to be left up to health experts and scientists.”
NORML Says DEA’s Newly Proposed Bulk Cultivation Rules Are “Unduly Onerous, Expensive, and Impractical”
“These new rules are unduly onerous, expensive, and impractical. Even if they are ultimately implemented, it is unlikely that they would greatly facilitate clinical cannabis research in the United States.”
Court Dismisses Case Demanding DEA to Move Expeditiously to License Cannabis Cultivators
A federal court on Friday denied a petition for a writ of mandamus that sought to order the US Drug Enforcement Administration to begin licensing private entities that wish to cultivate cannabis.
Why Dr. Sue Sisley Sued the DEA for Stonewalling Cannabis Research
We also spoke with her attorneys, who explained why they believed the DEA broke the law by holding up long-promised medical marijuana research licenses.
DEA Promises Progress on Federal Cultivation Applications, But Provides No Timetable for Action
“For the past three years, the DEA has failed to take any steps to follow through on its promise to facilitate clinical cannabis research, and today’s announcement makes it clear that this foot-dragging will continue,” NORML Executive Director Erik Altieri said.
US Government Approves Increased Production of Marijuana for Clinical Research
Federal officials have approved plans for the University of Mississippi to grow 2,000 kilograms (4,409 pounds) of cannabis to provide to investigators for clinical trial research.
Study: Marijuana Provided For FDA-Approved Clinical Research Genetically Similar to Hemp
Marijuana grown by the University of Mississippi for clinical research purposes is genetically divergent from strains of cannabis commercially available in retail markets, according to an analysis prepared by researchers at the University of Northern Colorado.
Justice Department Urged To Take “Immediate Action” On Marijuana Grow Applications
Newly appointed US Attorney General William Barr is being urged to review more than two-dozen pending applications for federal marijuana grow licenses which have languished before the agency for over two years.
Legislation Introduced To End The Federal Government’s Marijuana Production Monopoly
A bipartisan coalition of over two-dozen federal lawmakers, including House Judiciary Chairman Bob Goodlatte (R-VA) and Matt Gaetz (R-FL), are backing newly introduced legislation — The Medical Cannabis Research Act of 2018 — to facilitate federally-approved clinical trials involving cannabis. Passage of this act would end the University of Mississippi’s existing monopoly on the growth of cannabis for clinical research purposes by requiring the licensing of additional manufacturers.